Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

BMS builds on BridgeBio alliance, inking deal for rights to KRAS cancer drug – MedCity News,

The BridgeBio drug, BBP-398, is a small molecule designed to block SHP2, … Both parties agreed to co-fund the clinical trials. Promoted., The BridgeBio drug, BBP-398, is a small molecule designed to block SHP2, … Both parties agreed to co-fund the clinical trials. Promoted., Read More

Scroll to Top